NPPES file of Aug 9, 2026

Allison Megan Flores, PHARMD

Ambulatory Care Pharmacist · Los Angeles, CA

Allison Megan Flores, PHARMD is an ambulatory care pharmacist with a practice address in Los Angeles, California, and NPI 1295418945, issued on Aug 9, 2023. Check the license (California 86538, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1295418945
Name
Allison Megan Flores
Credential
PHARMD
Primary taxonomy
Ambulatory Care Pharmacist 1835P2201X
License number
86538 CA
Self-reported in NPPES; status is on the state search
Practice location
2051 Marengo St, Los Angeles, CA 90033
Phone
(323) 409-1000
Enumerated
Aug 9, 2023
Record last updated
Aug 9, 2023
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 2051 Marengo St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Helen AbolarinPsychiatric/Mental Health Nurse Practitioner1407551740
  2. Nawal AbouzahrStudent in an Organized Health Care Education/Training Program1881054104
  3. Shelby AdlerPsychiatry Physician1407432263
  4. Shalleymar AgitoRegistered Respiratory Therapist1649850694
  5. Adolfo AguilarCritical Care Registered Respiratory Therapist1053836999
  6. Ashley Allen, MDEmergency Medicine Physician1053751875

Verify Allison Megan Flores in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license 86538
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

72% fewer Medicare Part D claims than the average ambulatory care pharmacist in 2024

147 Medicare Part D claims for 26 beneficiaries, against an average of 527 among the 449 providers of this specialty who prescribed in Part D. Brand-name drugs were 43% of claims.

  1. Allison Flores147
  2. Specialty average527

Most prescribed

  1. Entresto27 claims
  2. Carvedilol24 claims
  3. Jardiance16 claims
  4. Atorvastatin Calcium15 claims
  5. Xarelto14 claims
  6. Spironolactone11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Allison Megan Flores among 485 ambulatory care pharmacist records in California

Allison Megan Flores, PHARMD is one of 485 ambulatory care pharmacist records with a practice address in California. 39% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2023, is newer than 82% of them.

  • NPI issued2023 · 82% of these records are older, 13% newer
  • In a Medicare fileYes · 39% of these records are
  • In the CMS Doctors and Clinicians fileNo · under 1% of these records are
  • Record last updated2023 · 57% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 1835P2201X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Ambulatory Care Pharmacist providers in California

There are 485 ambulatory care pharmacist records in California.

The 8 ambulatory care pharmacist records with the nearest ZIP codes

  1. Dalia Ameripour, PHARMDLos Angeles, CA 900331255060075
  2. Talin Bchakjian, PHARMDLos Angeles, CA 900331700450095
  3. Matthew Spencer Ocampo, PHARMDLos Angeles, CA 900331518843259
  4. Arvee OukLos Angeles, CA 900331790354256
  5. Catherine Su, PHARMDLos Angeles, CA 900331649739012
  6. Alena Hwang, PHARM.D.Los Angeles, CA 900341124215686
  7. Thao Mokulehua, PHARM DLos Angeles, CA 900341548917560
  8. Krysty Avila, PHARMDLos Angeles, CA 900371548747652

Common questions

What is Allison Megan Flores, PHARMD's NPI number?

Allison Megan Flores, PHARMD's National Provider Identifier (NPI) is 1295418945, issued on Aug 9, 2023. An NPI identifies a provider in billing; it is not a license.

Where is Allison Megan Flores, PHARMD located?

The NPPES record lists a practice address at 2051 Marengo St, Los Angeles, CA, 90033. Phone: (323) 409-1000. Providers update this record themselves, so call before visiting.

How can I verify Allison Megan Flores, PHARMD's license?

NPPES lists California license number 86538, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

How much does Allison Megan Flores, PHARMD prescribe under Medicare Part D?

In 2024, Allison Megan Flores, PHARMD had 147 Medicare Part D claims for 26 beneficiaries; the average among ambulatory care pharmacist prescribers was 527. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.